BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2904525)

  • 1. Improvement of hepatic encephalopathy treated with flumazenil.
    Grimm G; Ferenci P; Katzenschlager R; Madl C; Schneeweiss B; Laggner AN; Lenz K; Gangl A
    Lancet; 1988 Dec; 2(8625):1392-4. PubMed ID: 2904525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine antagonist in the treatment of human hepatic encephalopathy.
    Ferenci P; Grimm G
    Adv Exp Med Biol; 1990; 272():255-65. PubMed ID: 2103692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hepatic encephalopathy (HE) with the benzodiazepine antagonist flumazenil: a pilot study.
    Meier R; Gyr K
    Eur J Anaesthesiol Suppl; 1988; 2():139-46. PubMed ID: 2842130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electroencephalographic study of the effect of a benzodiazepine antagonist in hepatic encephalopathy].
    Pidoux B; Zylberberg P; Valla D; Opolon P
    Neurophysiol Clin; 1989 Dec; 19(6):469-76. PubMed ID: 2559309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.
    Bansky G; Meier PJ; Riederer E; Walser H; Ziegler WH; Schmid M
    Gastroenterology; 1989 Sep; 97(3):744-50. PubMed ID: 2546850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of acute hepatic encephalopathy with flumazenil].
    Viel E; de La Coussaye JE; Bassoul B; Saissi G; Eledjam JJ
    Ann Fr Anesth Reanim; 1990; 9(4):386-9. PubMed ID: 2119157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Benzodiazepine antagonists in the treatment of heptic encephalopathy].
    Ferenci P; Grimm G
    Leber Magen Darm; 1989 Dec; 19(6):322-5. PubMed ID: 2575692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evoked potentials and the effect of flumazenil in patients with liver cirrhosis.
    Ozyilkan E; Kahraman H; Onar M; Kesim G; Arik Z
    East Afr Med J; 1997 Apr; 74(4):210-2. PubMed ID: 9299818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy.
    Als-Nielsen B; Kjaergard LL; Gluud C
    Cochrane Database Syst Rev; 2001; (4):CD002798. PubMed ID: 11687160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
    Pomier-Layrargues G; Giguère JF; Lavoie J; Perney P; Gagnon S; D'Amour M; Wells J; Butterworth RF
    Hepatology; 1994 Jan; 19(1):32-7. PubMed ID: 8276366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current possibilities in the therapy of hepatic encephalopathy].
    Meier PJ; Bansky G
    Schweiz Med Wochenschr; 1990 Apr; 120(15):553-6. PubMed ID: 2159659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hepatic encephalopathy with flumazenil].
    Elkjaer JM; Jensen TU; Emborg J
    Ugeskr Laeger; 2000 Aug; 162(35):4681-4. PubMed ID: 10986901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flumazenil in the treatment of portal systemic encephalopathy--an overview.
    Gyr K; Meier R
    Intensive Care Med; 1991; 17 Suppl 1():S39-42. PubMed ID: 1774410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil.
    Ferenci P; Grimm G; Meryn S; Gangl A
    Gastroenterology; 1989 Jan; 96(1):240-3. PubMed ID: 2491822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat.
    Bosman DK; van den Buijs CA; de Haan JG; Maas MA; Chamuleau RA
    Gastroenterology; 1991 Sep; 101(3):772-81. PubMed ID: 1650320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzodiazepine receptor antagonists for hepatic encephalopathy.
    Als-Nielsen B; Gluud LL; Gluud C
    Cochrane Database Syst Rev; 2004; (2):CD002798. PubMed ID: 15106178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure.
    Bassett ML; Mullen KD; Skolnick P; Jones EA
    Gastroenterology; 1987 Nov; 93(5):1069-77. PubMed ID: 2820828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flumazenil does not improve hepatic encephalopathy associated with acute ischemic liver failure in the rabbit.
    van der Rijt CC; de Knegt RJ; Schalm SW; Terpstra OT; Mechelse K
    Metab Brain Dis; 1990 Sep; 5(3):131-41. PubMed ID: 2273999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do benzodiazepine ligands contribute to hepatic encephalopathy?
    Jones EA; Basile AS; Yurdaydin C; Skolnich P
    Adv Exp Med Biol; 1993; 341():57-69. PubMed ID: 8116487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study.
    Van der Rijt CC; Schalm SW; Meulstee J; Stijnen T
    Gastroenterol Clin Biol; 1995; 19(6-7):572-80. PubMed ID: 7590022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.